Skip to main content
Bristol-Myers Squibb India

Bristol-Myers Squibb India is a subsidiary of Bristol-Myers Squibb — a global biopharmaceutical company headquartered in New York City. Our mission is to to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

At Bristol-Myers Squibb, we take our mission to extend and enhance human life seriously. Since 2002, we have introduced nine new products to the global market for the treatment of psychiatric disorders, cancer, HIV, chronic hepatitis B, rheumatoid arthritis and other serious diseases. Two of these medications are biologic products. In the fight against serious disease, biologics — or protein-derived therapies — are playing an increasingly prominent role. In addition, other biologic compounds, as well as scores of additional investigational medicines are advancing through our pharmaceutical development pipeline to address unmet medical need in diseases such as cardiovascular disease, solid organ transplant rejection, Alzheimer’s disease and obesity. Bristol- Myers Squibb is recognized as having one of the most productive pipelines in the industry.

Bristol-Myers Squibb commenced current operations in India in 2004 with a strategy closely aligned to its global focus: to fulfill unmet medical needs. Today, more than 100 employees work at the company’s headquarters in Mumbai. Growth in India continues to gain momentum with the company’s recent announcement to expand Research and Development (R&D) capabilities in India. The company is increasing the scope of its relationship with Biocon Limited, India’s premier biotech company, and expanding its relationship with Accenture, a global management consulting, technology services and outsourcing company.

Our Commitment in India

As part of the company’s strategy to transform to a next-generation BioPharma leader, Bristol-Myers Squibb established an R&D presence in Asia. India was chosen partly due to factors such as access to a large pool of skilled and knowledgeable talent, high-quality standards of academic research, increased commitment to protecting intellectual property (IP) rights, conducive infrastructure, established capabilities, committed work ethics, and a productive labor market.



Explore the history of Bristol-Myers Squibb
View timeline

   Mission & Commitment

Our company’s mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.    Read More >>

From the desk of Country Head Mr. Jitendra Tyagi.

© 2015 Bristol-Myers Squibb Company Legal Notice   »   Privacy Policy   »  Trademarks